References
- Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 2003; 41: 7S–14S
- Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll of Cardiol 2003; 41: 15S–22S.
- Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST- elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–42.
- Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004; 350: 232–8.
- Cohen M. The Low-Molecular-Weight Heparin in the management of acute coronary syndromes. J Am Coll Cardiol 2003; 41: 55S–61S
- Bybee KY, Wright RS, Kopecky SL. Effect of early statin therapy after acute coronary syndromes: a concise review of the recent data. Cardiology in Review 2002; 10:301–5
- Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002; 359: 189–98.